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Diabetes mellitus has been associated with lipid abnormalities and oxidative stress. Some 
phytochemical properties have been shown to possess antioxidant activities, improving the effects of 
oxidative stress on diabetes. This present investigations confirmed that untreated diabetic rats were 
associated with lipid abnormalities as indicated by high levels of total- and LDL-cholesterol, 
triacylglycerols and low levels of HDL-cholesterol and phospholipids, compared to non-diabetic rats 
(control). The aqueous extract of Phyllanthus niruri significantly normalized the serum lipids levels. The 
study also showed that untreated diabetic rats were subjected to oxidative stress as indicated by 
significantly abnormal activities of their scavenging enzymes (superoxide dismutase and catalase and 
significantly low levels of non-enzymic antioxidants (vitamin C, vitamin E and reduced glutathione) in 
liver and plasma when compared with controls and in the extent of lipid peroxidation (increased 
malondialdehyde levels) in plasma and liver cells. The aqueous extract of P. niruri possessed 
antioxidant activities as shown by increased activities of enzymic and non-enzymic antioxidants and 
decrease in malondialdehyde levels. 
 





Diabetes mellitus is a metabolic disease characterized by 
hyperglycaemia and glycosuria due to absolute or relative 
insulin deficiency (Aguwa, 1996). It is a multifactorial dis-
ease, which is also characterized by lipoprotein abnor-
malities (Scoppola et al., 2001). These traits are hypothe-
sized to damage cell membranes which results in elev-
ated production of reactive oxygen species (ROS). This 
generation of oxygen-free-radicals during cellular metab-
olism, and by certain environmental factors, including life 
style, appears to play a critical role in the pathogenesis of 
diabetes mellitus (Hartnelt et al., 2000). Hyperglycemia, 
the main symptoms of diabetes, not only increases the 
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et al., 1999). Diabetes has also been associated with an 
increased risk for developing premature arteriosclerosis 
due to increase in triacylglyceroles and low-density lipo-
protein levels and decrease in light density lipoprotein 
levels (Bierman, 1992). 
Recently, there has been increasing interest in the use 
of traditional medicinal plants in management of various 
disease conditions especially diabetes mellitus. Phyllant-
hus niruri, commonly called “Enyikwonwa” in Igbo land of 
the south Eastern part of Nigeria belongs to the family 
Euphorbiaceae. P. niruri has been claimed to be hypogl-
ycaemic and hepatoprotective by the traditional healers 
or herbalist in Eastern part of Nigeria and also by some 
researchers (Taylor, 2003; Mazumder et al., 2005). It is of 
medicinal importance for numerous ailments like dysen-
tery, influenza, viginitis, tumours, diabetes, diuretics, jau-
ndice, kidney stones, dyspepsia, antihepatotoxic, anti-





tibacterial (Chopra et al., 1986). 
Although P. niruri has been investigated for its various 
medicinal properties, detailed evaluation of its anti-lipop-
roteinaemic, antioxidant and lipid peroxidative potentials 
in diabetic rats are still lacking. In this study, we evalu-
ated the antioxidant potentials of an aqueous extract of P. 
niruri and its effects on enzymic and non-enzymic antioxi-
dants activities in hepapocytes of streptozotocin-induced 
rats. We also evaluated their effects on lipid peroxidation 
in liver by measuring malondialdehyde (MDA) Levels and 
on cholesterols and triacylglycerols levels in serum. 
 
 




Streptozotocin (STZ), thiobarbituric acid (TBA), butylated hydroxyto-
luene (BNT), reduced glutathione (GSH), 2,2,- dipyridyl, xynol 
orange, aspartic acid, alanine, -ketoglutarate, 2,4-dinitro phenyl 
hydrazine (DNPH), 5,5-dithiobis-2-nitrobenzoic acid (DTNB) were 
obtained from Sigma Chemical Co (St Louis, MO-USA). The rest of 
the chemical utilized were of analytical grade and were obtained 





The plant P. niruri was collected in the month of June, 2006 from 
the Imo State University Campus, Owerri, Nigeria. The plant was 
taxonomically identified and authenticated by Dr S. E. Okeke, 
Head, Department of Plant Science and Biotechnology, Imo State 
University, Owerri. The voucher samples were preserved in the 
university herbarium for future reference. 
 
 
Preparation of the aqueous plant extract 
 
The entire plant of P. niruri was sun dried for ten days before the 
final drying in an oven at 50C for 24 h. The dried plants were 
powdered in both manual grinder and electric grinder. 15 g of the P. 
niruri powder was soaked with 350 ml of distilled water in a beaker 
and the mixture shaken on the laboratory bench for 24 h before 
filtering. The filtrate was then evaporated by hot-air oven treatment 
at 40 - 50C. Appropriate weights of the residue were prepared in 






Male Wistar rats (200 – 300 g) bred in the Animal House of College 
of Medicine and Health Sciences, Imo State University, Owerri were 
used in this study. They were housed in stainless steel cages and 
kept in a room where a 12 h light/dark cycle was maintained. They 
were allowed free access to water and feed diet (product of Pfizer 
Nigeria Ltd) ad libitum throughout the period of the experiment.  
 
 
Induction of diabetes in rats 
 
After one week of acclimatization, the rats were subjected to a 16 h 
fast. Diabetes was induces with a single intraperitoneal injection of 
streptozotocin (STZ) at a dose of 65 mg/kg body weight. The STZ 
was  freshly  dissolved  in  citrate  buffer  (0.01 m,  pH  4.5) (Ozsoy- 




Sacan, 2000). The injection volume was prepared to contain 1.0 
ml/kg (Murali et al., 2002). After 5 days, blood glucose levels were 
measure and the animals with a concentration of more than 230 





Twenty four male Wistar rats were used in this study. The rats were 
randomized and divided into four groups of six animals each. 
 
Group 1: Normal, received normal saline solution (0.9% NaCl, 5 
ml/kg). 
Group 2: Diabetic, received STZ (65 mg/kg body weight) once 
Group 3: Diabetic, receive STZ (65 mg/kg body weight) once 
before receiving aqueous extract of P. niruri (120 mg/kg 
body weight) 
Group 4: Diabetic received STZ (65 mg/kg body weight) once 
before receiving aqueous extract of P. niruri (240 mg/kg 
body weight). 
 
After 14 days of treatment, all the rats were decapitated after 
fasting for 16 h. Blood was collected in two different tubes i.e. one 
with fluoride oxalate anticoagulant for plasma separation and 
another without anticoagulant to separate serum for various bioch-
emical estimations. The livers were dissected out and cleared off 
blood. They were immediately transferred to ice-cold containers 
containing 0.9% NaCl and homogenized in 0.1 N Tris-Hcl buffer (pH 
7.4), and used for the estimation of malondialdehyde (MDA), redu-




Measurement of blood glucose levels 
 
The body weight and blood glucose levels were measured at the 
beginning and end of the experiment. Blood samples were obtained 
by tail vein puncture of both the normal and STZ-induced diabetic 
rats. Blood glucose levels were determined using a glucometer 
(Lifescan Johnson and Johnson Company, Milipitas, CA). 
 
 
Acute toxicity tests 
 
The acute toxicity of the extract was tested using 30 Wistar rats 
divided into 5 groups of 6 rats each, with each group receiving 
graded dose (250 - 1500 mg/kg body weight, intraperitoneally) of 
the aqueous extract of P. niruri as described by Ghosh (1984). After 
administration of the extract the rats were observed for toxic effects 
after 48 h treatment. The toxicological effects were observed in 
terms of mortality expressed as LD50. The number of animals dying 
during a period was noted. The LD50 of the extract was estimated 
from the graph of percentage (%) mortality (converted to probit) 




Estimation of serum lipids 
 
Extraction of lipids from serum carried out according to the proce-
dure of Folch et al. (1957) by using chloroform-methanol (2:1, v/v) 
mixture. From this total cholesterol LDL- and HDL-cholesterol triac-
ylglyceroles and phospholipids were estimated as earlier described 
(Nwanjo, 2005; Nwanjo and Ojiako, 2005). 
 
 
Estimation of lipid peroxidation 
 
Lipid peroxidation in plasma and liver was estimated colorimetrically  




Table 1. Mean values of body weight and blood glucose in experimental and control rats. 
 
Body weight (g) Fasting blood glucose (mg/dl) Treatment 
Initial Final change Initial Final 
Control (Group 1) 180.8 ± 6.2 198.82 ± 8.4 18.2 ± 4.0** 96.34 ± 12.8 82.8  ± 10.5 
Diabetic Group II 182.2 ± 4.4 158.71± 6.9 -23.49 ± 3.2 230.56 ± 20.0 262.4 ± 32.0 
Diabetic + 120 mg/kg P. niruri  (Group III) 183.4 ± 6.8 192.26 ± 5.2 8.86 ± 2.6* 231.23 ± 11.6 138.92± 13.2# 
Diabetic + 240 mg/kg P. niruri  (Group IV) 180.9 ± 10.8 196.98 ± 112 16.08±4.4** 231.89 ± 13.2 97.9  ± 6.8 # 
 
*Significantly different from diabetic rats (group II) (P < 0.05). 
**Significantly different from group II and group III (P < 0.05). 




by measuring malondialdehyde (MDA) by the method of Nichans 
and Samualson (1968). In brief, 0.1 ml of plasma was treated with 2 
ml of (1:1:1 ratio) TBA-TCA-HCL reagent (TBA 0.37%: 0.25 N HCL: 
15% TCA) and placed in water bath for 15 min, cooled and 
centrifuged and then clear supernatant was measured at 535 nm 
against reference blank. 
 
 
Estimation of enzymic antioxidants 
 
Superoxide dismutase (SOD) activity was determined by the modi-
fied method of NADH-phenazinemethosulphate-nitrobluete-trazo-
lium formazon inhibition reaction spectrophotometrically at 560 nm 
(Kakkar et al., 1984). A single unit of enzyme was expressed as 
50% inhibition of NBT (nitroblue tetrazolium) reduction /min/mg 
protein.  
Catalase (CAT) was assayed calorimetrically as described by 
Sinha (1972) using dichromate-acetic acid reagent (5% potassium 
dichromate and glacial acetic acid were mixed in 1.3 ratio). The 
intensity was measured at 620 nm and the amount of hydrogen 
peroxide hydrolyzed was calculated for the catalase activity. 
 
 
Estimation of non-enzymic antioxidants 
 
Reduced glutathione (GSH) was determined by the method of 
Ellman (1959). 1 ml of supernatant (0.5 ml plasma/0.5 ml liver hom-
ogenate precipitated by 2 ml of 5% TCA) was taken and 0.5 ml of 
Ellman’s reagent (0.0198% DTNB in 1% sodium citrate) and 3 ml of 
phosphate buffer (pH 8.0) were added. The colour developed was 
read at 412 nm.  
Vitamin C (ascorbic acid) concentration was measured by Omaye 
et al. (1979) method. To 0.5 ml of plasma/0.5 ml liver homogenate, 
1.5 ml of supernatant, 0.5 ml of DNPH reagent (2% DNPH) and 4% 
thiourea in 9 N sulphuric acid) was added and incubated for 3 h at 
room temperature. After incubation 2.5 ml of 8.5% sulphuric acid 
was added and colour developed was read at 530 nm after 30 min.  
Vitamin E (-tocopherol) was estimated by the method of Desai 
(1984). Vitamin E was extracted from plasma/liver homogenate by 
addition of 1.6 ml ethamol and 2.0 ml petroleum ether to 5.0 ml 
plasma and centrifuged. The supernatant was separated and eva-
porated. To the residue, 0.2 ml of 0.2% 2,2-dipyridyl, 0.2 ml of 0.5% 
ferric chloride was added and kept in dark for 5 min, an intense red 






Statistical evaluation of data was performed by using one-way 
analysis of variance ANOVA followed by Duncan’s multiple range 





Effect of extract of P. niruri on blood glucose levels 
and body weight changes  
 
The results of blood glucose levels and body weight cha-
nges in normal, STZ-induced diabetic rats and P. niruri 
treated diabetic rats were shown in Table 1. There was a 
significant (p < 0.01) increase in blood glucose levels in 
STZ-induced diabetic rats (Group II) when compared with 
normal rats. Administration of aqueous extract of P. niruri 
at a dose of 120 and 240 mg/kg body weight significantly 
(p < 0.05) decreased blood glucose in STZ induced rats 
(Group III and IV). The results were found to be in a dose 
dependent manner.  
The body weight in the diabetic group was significantly 
less (p < 0.05) than the normal control which then retur-
ned to near normal in diabetic rats treated with aqueous 




Effect of aqueous extract of P. niruri on serum lipids 
 
The changes in the levels of serum lipids in control and 
experimental rats are illustrated in Table 2. The total chol-
esterol, LDL-Cholesterol and triacylglycerol signific-antly 
increased and HDL-Cholesterol and phospholipids signi-
fycantly decreased in STZ-induced diabetic rats (group II) 
(P < 0.05) when compared with the normal (group I) rats. 
The aqueous extract of P. niruri (120 mg/kg and 240 
mg/kg body weight) offered a significant protection aga-
inst alteration in the serum lipids of diabetic rats. The res-
ults were also dose dependent.  
 
 
Effects of P. niruri aqueous extract on MDA 
 
The levels of MDA in plasma and liver were significantly 
(p < 0.05) increased in STZ-induced rats as compared to 
normal  rats. Treatment  with  aqueous extract of P. niruri  
















Control (Group 1)  92.1 ±8.62** 46.2 ± 3.58* 31.99 ±2.0** 69.55 ±3.4** 92.3  ±6.5* 
Diabetic (Group II) 172.5 ±9.5 30.2 ±4.2 100.68 ± 4.2 158.1 ± 8.4 65.1 ± 3.2 
Diabetic + 120 mg/kg P. niruri  (Group III) 130.66 ±10.6* 42.8 ± 3.6* 66.22 ±3.5* 108.2 ±5.8* 80.2 ± 6.1* 
Diabetic + 240 mg/kg P. niruri  (Group IV) 98.9 ± 9.22** 37.82 ±3.9* 44.66 ±3.8** 82.1 ± 6.1** 88.3 ± 5.6* 
 
*Significantly different from diabetic rats (Group II) (P < 0.05). 
**Significantly different from group II and group III (P < 0.05). 
 
 
Table 3. Mean values of plasma and liver lipid peroxidation in experimental and control rats. 
 
Treatment Plasma MDA (nmol/ml) Liver MDA (nmol /ml) 
Control (Group I) 2.92 ± 0.48* 10.42 ±2.9* 
Diabetic (Group II) 6.89 ± 1.04 25.26 ± 4.8 
Diabetic + 120 mg/kg P. niruri  (Group III) 4.26 ± 0.98* 14. 48 ± 3.6* 
Diabetic + 240 mg/kg P. niruri  (Group IV) 3.68 ± 1.12* 12.87 ±4.1* 
 
*Significantly different from the diabetic (p < 0.05) 
 
 
Table 4. Mean activities of liver of enzymic antioxidant in both experimental and control rats. 
 
Treatment Liver SOD (units/mg protein) Liver CAT (units/mg protein) 
Control (Group I)  5.89 ± 0.56* 70.56 ± 5.3* 
Diabetic (Group II) 3.01 ± 0.58 46.2 ± 4.6 
Diabetic + 120 mg/kg P. niruri  (Group III) 4.99 ± 0.42* 62.34 ± 3.8* 
Diabetic + 240 mg/kg P. niruri  (Group IV) 5.04 ± 1.21* 65.22 ± 4.02* 
 




Table 5.  Mean values of plasma and liver non-enzymic antioxidant in experimental and control rats. 
 
GSH (mg/dl) Vitamin C (mg/dl) Vitamin E (mg/dl) Treatment 
Plasma Liver Plasma Liver Plasma Liver 
Control (Group I) 19.82 ± 0.8* 38.2 ± 3.5* 1.39 ± 0.3* 1.28 ± 0.16* 1.71 ± 0.2* 0.91± 0.04* 
Diabetic(GroupII) 10.45 ± 1.7 19.67±2.8 0.69 ± 0.2 0.68 ± 0.08 0.83 ± 0.15 0.52 ±0.04 
Diabetic + 120 mg/kg P. niruri  (Group III) 16.12 ± 0.9* 32.2 ±3.4* 1.21± 0.32* 1.25 ± 0.08* 1.42 ±0.13* 0.87 ± 0.04* 
Diabetic + 240 mg/kg P. niruri  (Group IV) 18.0 ±1.33* 35.8 ±2.99* 1.22 ± 0.29* 1.30 ±0.11* 1.61 ±0.15* 0.88 ±0.3* 
 




resulted in a significantly decrease in the levels of lipid 
peroxidation products (MDA) in diabetic rats (Table 3). 
 
 
Effects of P. niruri aqueous extract on enzymic 
antioxidant status 
 
A significant decrease (P < 0.05) in the activities of enz-
ymic antioxidants such as superoxide dismutase (SOD) 
and catalase (CAT) of the liver was noted in STZ-induced 
diabetic rats when compared with the normal rats. Upon 
administration of 120 and 240 mg/kg body weight of 
aqueous extract of P. niruri, the activities of both SOD 
and CAT were significantly reversed to near normal 
(Table 4).  
 
 
Effects of P. niruri aqueous extract on non-enzymic 
antioxidant status  
 
The levels of plasma and liver vitamins C, E and reduced 
glutathione (GSH) were significantly depleted in STZ-
induced diabetic rats. Treatment with aqueous extract of 
P. niruri significantly increased the levels of these non-
enzymic antioxidants in diabetic rats (Table 5).  






This study demonstrated the hypoglycemic, hypolipidae-
mic and antioxidant effect of aqueous extract of P. niruri 
in STZ-induced diabetic rats. Streptozotocin induction 
causes a significant elevation in the level of blood gluc-
ose and loss of body weight in rats. In this study we 
observed that the administrated of aqueous extract of P. 
niruri at the doses of 120 and 240 mg/kg body weight to 
diabetic rats not only caused a significant decrease in 
blood glucose but also has a significant effect in 
controlling the loss of body weight, which is caused 
during diabetes. High level of blood glucose, the primary 
clinical manifestation in diabetes, is associated with 
certain complications of diabetes. Brownlee et al. (1981) 
reported that in diabetic there is increase in cholest-
erol/phospholipids ratio, thereby disrupting membranes 
fluidity and leading to membrane alteration of function. In 
agreement with this, we also observed that the levels of 
serum lipids significantly changed in diabetic rats, 
suggesting that hyperglycemia has devastating effect on 
membrane stability and functional state. Similar results 
were observed in our previous study (Nwanjo, 2005). 
Administration of aqueous extract of P. niruri at doses of 
120 and 240 mg/kg body weight showed protection agai-
nst serum lipid changes in STZ-induced diabetic rats. The 
activities were found to be in a dose dependent manner. 
Membrane lipids succumb easily to deleterious actions 
of reactive oxygen species (ROS) (Reiter, 1995). ROS 
induce oxidative tissue damages plays an important role 
in many clinical disorders such as heart disease, diabe-
tes, gout and cancer associated with the peroxidation of 
cellular lipids, which is determined by measurement of 
thiobarbituric acid (TBA)-reactive substance. The conce-
ntration of lipid peroxidation products may reflect the 
degree of oxidative stress in diabetes. It has been repo-
rted previously (Baynes, 1991; Kakkar et al., 1995) that in 
tissues and blood of rats with STZ- induced diabetes, 
malondialdehyde, one of the by-products of lipid peroxi-
dation is increased. Further, increased level of TBA-reac-
tive substances results in increased levels of oxygen free 
radicals, which attack the polyunsaturated fatty acid in 
cell membranes and cause lipid peroxidation. STZ is toxic 
to pancreatic -cells and is thus widely used for induction 
of experimented diabetes in animals. It can give rise to 
oxygen free radicals because of the increased blood 
glucose level in diabetes (Rakieten et al., 1963). The 
measurement of lipid peroxidation is a convenient meth-
od to monitor oxidative damage (Viani et al., 1991). In 
this study, the increased level of TBA-reactive substa-
nces in plasma and liver of STZ-induced diabetic rats 
reflected the lipid peroxidation as the consequence of 
oxidative stress caused by increased blood glucose 
levels in diabetes. Treatment with aqueous extract of P. 
niruri protects the cells through attenuation of lipid perox-
idation and decreased the production of free radical deri-





and liver TBA-reactive substances. Thus aqueous extr-
act P. niruri offered protection against oxidative stress by 
scavenging of free radicals. 
The enzymic antioxidants defense systems are the 
nature protector against lipid peroxidation. SOD scave-
nges the superoxide ions produced as cellular by prod-
ucts. SOD is a major defense for aerobic cells in comb-
ating the toxic effects of superoxide radicals (McCord et 
al., 1976). CAT reduces hydrogen peroxide produced by 
dismutation reaction and prevents generation of hydroxyl 
radicals thereby protecting the cellular constituents from 
oxidative damage in peroxisomes. The reduced activities 
of SOD and CAT in STZ-induced diabetic rats resulted in 
the accumulation of superoxide radical and H2O2 respect-
ively, which produce deleterious effects (Mazunder et al., 
2005). Administration of aqueous extract of P. niruri 
showed normalization of activities of SOD and CAT in 
liver of STZ- induced diabetic rats. 
Non-enzymic antioxidats such as reduced glutathione 
(GSH), Vitamin C and Vitamin E play an excellent role in 
protecting the cells from oxidative damage (Anuradha 
and Selvam, 1993). GSH is a major endogenous non-
enzymic antioxidant which counter balance free radicals 
mediated damage. It is well established that GSH is 
involved in the protection of normal cell structure and 
function by maintaining the redox homeostasis, quen-
ching of free radicals by participation in detoxification 
reaction and keeps up the cellular levels of the active 
forms of Vitamin C and vitamin E by neutralizing the free 
radicals. When there is a reduction in GSH the cellular 
levels of vitamin C and vitamin E are closely inter linked 
to each other (Pari and Amadi, 2005). In agreement with 
this report, the decreased levels of GSH, vitamin C and 
Vitamin E on STZ-induced diabetic rats were observed in 
this study. Administration of aqueous extract of P. niruri 
to these diabetic rats, maintained the level of non-
enzymic antioxidants to near normal by the possible role 
of this extract in improving the GSH status. 
In conclusion, P. niruri exhibits strong hypoglycemic 
and hypolipidamic activities. Our study also showed that 
aqueous extract of P. niruri have antioxidant activity. 
Therefore aqueous extract of P. niruri is suggested to be 
effective for reducing oxidative stress and free radical-
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